4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Modulator-Ineligible/-Intolerant Cystic Fibrosis at 47th European Cystic Fibrosis Conference
June 06, 2024 07:30 ET
|
4D Molecular Therapeutics, Inc.
Clinically meaningful improvements in ppFEV1 at 12 months observed in 2 of 3 participants with mild to moderate baseline lung function impairment (ppFEV1 50-80%) and >6 months follow up ...
BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference
June 06, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
PALO ALTO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases...
Virbac : Déclaration d'actions et de droits de vote 05/2024
June 06, 2024 07:08 ET
|
Virbac
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital(Article 223-16 du Règlement Général de l’Autorité des...
Virbac : Declaration of the number of shares and voting rights 05/2024
June 06, 2024 07:08 ET
|
Virbac
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the...
Cartesian Therapeutics Announces New Employment Inducement Grant
June 06, 2024 07:05 ET
|
Cartesian Therapeutics, Inc.
GAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the...
PetVivo Appoints Former NOVUS and Colgate-Palmolive Senior Sales & Marketing Executive, Bryan Monninger, as VP of Sales
June 06, 2024 07:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, June 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and...
Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference
June 06, 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab presents new data supporting clinical potential of CM-101 as novel treatment for PSC at EASL 2024 and Gordon Research Conference
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
June 06, 2024 07:00 ET
|
Relay Therapeutics, Inc.
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 06, 2024 07:00 ET
|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Redecan Cannabis Introduces New Top Shelf Flower 'Purple Churro'
June 06, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray's Canadian cannabis brand Redecan launches 'Purple Churro' – a sensational new flower offering making its debut in time for National Churro Day.